R

RANI

Rani Therapeutics Holdings, Inc.

0.73

-0.05-5.93%
After Hours: 0.7500  +0.0200  +2.74%19:40 05/09 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

1.03M

0

0

2.72M

462.00K

Revenue

1.03M

--

0

2.72M

462.00K

Other Revenue, Total

--

--

--

--

--

Cost of Revenue, Total

--

--

--

--

--

Gross Profit

--

--

--

--

--

Operating Expense

54.34M

66.10M

63.45M

55.02M

17.01M

Selling/General/Admin.Expenses,Total

23.95M

26.48M

26.84M

27.83M

4.96M

Research & Development

26.68M

39.62M

36.61M

26.48M

12.04M

Depreciation/Amortization

--

--

--

--

--

Interest Exp.(Inc.), Net-Operating, Total

--

--

--

--

--

Unusual Expense (Income)

3.71M

--

0

700.00K

--

Other Operating Expenses, Total

--

--

--

--

--

Operating Income

-53.31M

-66.10M

-63.45M

-52.30M

-16.54M

Interest Inc.(Exp.),Net-Non-Op.,Total

-3.27M

-1.78M

177.00K

-377.00K

-61.00K

Gain(Loss) on Sale of Assets

--

--

--

--

--

Other, Net

--

--

0

-371.00K

-63.00K

Net Income Before Taxes

-56.58M

-67.88M

-63.27M

-53.05M

-16.67M

Provision for Income Taxes

0

0

70.00K

41.00K

35.00K

Net Income After Taxes

-56.58M

-67.88M

-63.34M

-53.09M

-16.70M

Minority Interest

-26.57M

-33.91M

-32.76M

-44.76M

--

Equity in Affiliates

--

--

--

--

--

U.S. GAAP Adjustment

--

--

--

--

--

Net Income Before Extra. Items

-30.02M

-33.97M

-30.59M

-8.33M

-16.70M

Total Extraordinary Items

--

--

--

--

--

Net Income

-30.02M

-33.97M

-30.59M

-8.33M

-16.70M

Total Adjustments to Net Income

--

--

--

--

--

Income Available to Com Excl ExtraOrd

-30.02M

-33.97M

-30.59M

-8.33M

-16.70M

Income Available to Com Incl ExtraOrd

-30.02M

-33.97M

-30.59M

-8.33M

-16.70M

Dilution Adjustment

--

--

--

--

--

Diluted Net Income

-30.02M

-33.97M

-30.59M

-8.33M

-16.70M

Diluted Weighted Average Shares

28.48M

25.50M

23.82M

19.53M

48.01M

Diluted EPS Excluding ExtraOrd Items

-1.05415

-1.3319

-1.28429

-0.42649

-0.34792

Diluted EPS including ExtraOrd Items

-1.054151

-1.331896

-1.284293

-0.426487

-0.34792

DPS – Common Stock Primary Issue

--

--

--

--

0

Diluted Normalized EPS

-0.92373

-1.3319

-1.28429

-0.40319

-0.34792